Working Out Payment

Only a handful of people have been treated with Kite Pharmaceuticals' Yescarta  since its approval, Bloomberg reports. The CAR T-cell therapy received approval from the US Food and Drug Administration to treat large B-cell lymphoma in October.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.